Use of Adjunctive Aerosolized Antimicrobial Therapy in the Treatment of <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i> Ventilator-Associated Pneumonia

Abstract

Patients with PA and AB VAP may experience favorable survival when treated with AAA, despite greater severity of illness and a greater incidence of multidrug-resistant infection. Large randomized trials are needed to further explore this therapy.